Patent ID: 8455515
Filing Date: 2013-06-04
Classification: A61P,C07D

Abstract:
1. A compound of formula I wherein: R1, R2, R3 and R4 are each independently selected from the group consisting of hydrogen, F, Cl, Br, I, CN, NO R5 is selected from the group consisting of hydrogen, alkyl having 1, 2, 3, 4, 5 or 6 carbon atoms and cycloalkyl having 3, 4, 5 or 6 carbon atoms; R6 is selected from the group consisting of hydrogen, OH, F, CF R7 and R8 are each independently selected from the group consisting of hydrogen, F, Cl, Br, CN, CO R12 is independently selected from the group consisting of hydrogen, alkyl having 1, 2, 3 or 4 carbon atoms and cycloalkyl having 3, 4, 5 or 6 carbon atoms; R13 and R14 are each independently selected from the group consisting of hydrogen, alkyl having 1, 2, 3 or 4 carbon atoms and cycloalkyl having 3, 4, 5 or 6 carbon atoms; or R13 and R14, together with the nitrogen atom to which they are bonded, form a 4-, 5-, 6- or 7-membered ring in which one CH R15 is selected from the group consisting of hydrogen, alkyl having 1, 2, 3 or 4 carbon atoms and cycloalkyl having 3, 4, 5 or 6 carbon atoms; or a pharmaceutically acceptable salt or trifluoroacetate thereof.